COM:HYLORIS
Hyloris Pharmaceuticals
- Stock
Last Close
5.80
22/11 16:35
Market Cap
327.60M
Beta: -
Volume Today
60.81K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|
asset turnover | 0.05 - | 0.01 76.54% | 0.02 32.84% | 0.00 83.37% | 0.05 1,829.15% | 0.05 2.25% | 0.06 23.90% | ||
cash conversion cycle | -6.48K - | -5.33K 17.79% | -15.85K 197.43% | -4.01K 74.67% | -8.94K 122.77% | -8.94K 0.06% | -2.36K 73.65% | ||
cash per share | 0.01 - | 0.11 856.23% | 0.01 92.37% | 2.95 33,812.89% | 1.96 33.72% | 1.61 17.45% | 1.07 33.57% | ||
company equity multiplier | -0.61 - | -1.02 65.68% | -3.54 247.47% | -0.59 83.40% | 1.17 299.47% | 1.32 12.70% | 1.12 14.87% | 1.23 9.12% | |
days of inventory outstanding | 5.60K - | 0.00 - | |||||||
days of payables outstanding | 6.80K - | 11.55K 69.77% | 15.85K 37.28% | 4.01K 74.67% | 8.94K 122.77% | 8.94K 0.06% | 2.89K 67.70% | ||
days of sales outstanding | 318.73 - | 617.69 93.80% | 531.81 - | ||||||
dividend yield | |||||||||
ebit per revenue | -18.15 - | -60.10 231.12% | -57.96 3.57% | -31.87 45.01% | -3.34 89.51% | -3.56 6.54% | -6.28 76.45% | ||
ebt per ebit | 0.98 - | 1.11 13.22% | 1.10 1.04% | 1.28 16.86% | 1.09 14.90% | 1.02 6.03% | 0.88 13.80% | ||
effective tax rate | 0.02 - | 0.00 81.08% | 0.00 26.65% | -0.00 105.78% | -0.03 18,709.30% | -0.00 98.59% | -0.01 2,433.78% | ||
enterprise value multiple | -70.33 - | -44.64 36.53% | -124.79 179.54% | -26.67 78.63% | -38.64 44.89% | -26.69 30.92% | -19.27 27.81% | ||
fixed asset turnover | 6.09 - | 0.61 89.96% | 0.93 52.04% | 0.99 7.08% | 10.49 955.49% | 2.78 73.47% | 1.31 53.05% | ||
free cash flow per share | -0.19 - | -0.23 22.26% | -0.25 7.28% | -0.24 3.22% | -0.48 100.23% | -0.51 7.18% | -0.46 9.26% | ||
gross profit margin | 0.55 - | 0.29 48.43% | 0.27 3.85% | 0.17 37.60% | 0.97 463.17% | 0.97 0.28% | 0.84 12.93% | ||
interest coverage | -26.48 - | -16.09 39.25% | -12.83 20.22% | -5.62 56.19% | -18.61 231.05% | -47.98 157.81% | -44.99 6.24% | ||
inventory turnover | 0.07 - | 442K - | |||||||
long term debt to capitalization | 8.73 - | 2.72 68.87% | 1.32 51.51% | -0.00 100.16% | 0.12 5,607.19% | 0.01 92.92% | 0.01 58.65% | 0.05 240.43% | |
net income per ebt | 0.98 - | 0.96 2.73% | 1.00 4.37% | 1.00 0.26% | 1.03 2.62% | 1.00 2.53% | 1.01 0.90% | ||
net profit margin | -17.45 - | -63.64 264.67% | -63.38 0.40% | -40.83 35.58% | -3.74 90.84% | -3.65 2.42% | -5.60 53.48% | ||
operating cash flow per share | -0.07 - | -0.23 232.18% | -0.19 15.01% | -0.21 8.13% | -0.44 107.92% | -0.48 11.05% | -0.44 9.47% | ||
operating cycle | 318.73 - | 6.22K 1,850.30% | 531.81 - | ||||||
operating profit margin | -18.15 - | -60.10 231.12% | -57.96 3.57% | -31.87 45.01% | -3.34 89.51% | -3.56 6.54% | -6.28 76.45% | ||
payables turnover | 0.05 - | 0.03 41.10% | 0.02 27.16% | 0.09 294.77% | 0.04 55.11% | 0.04 0.06% | 0.13 209.62% | ||
pretax profit margin | -17.76 - | -66.58 274.89% | -63.54 4.57% | -40.83 35.74% | -3.64 91.07% | -3.65 0.12% | -5.55 52.10% | ||
price fair value | -57.09 - | -108.95 90.83% | -24.02 77.95% | 3.51 114.61% | 9.30 164.97% | 5.73 38.37% | 9.24 61.27% | ||
receivables turnover | 1.15 - | 0.59 48.40% | 0.69 - | ||||||
return on assets | -0.85 - | -0.73 14.44% | -0.96 32.32% | -0.10 89.29% | -0.18 76.69% | -0.17 4.61% | -0.33 90.16% | ||
return on capital employed | -1.55 - | -1.13 27.18% | 0.52 145.98% | -0.08 116.03% | -0.21 156.69% | -0.19 12.26% | -0.43 132.04% | ||
return on equity | 0.87 - | 2.58 197.31% | 0.57 78.04% | -0.12 121.37% | -0.24 99.13% | -0.20 18.80% | -0.41 107.51% | ||
total debt to capitalization | 8.20 - | 2.70 67.01% | 1.32 51.35% | 4.39 233.44% | 0.13 97.15% | 0.20 62.76% | 0.02 92.23% | 0.12 658.51% |
All numbers in (except ratios and percentages)